CDKN1A and cancer: Therefore, p21 can stimulate the formation of RB-E2F complex, but when p21 loses its function, it can be saved to some extent by CDK4/6 inhibitors such as palbociclib, abemaciclib, ribociclib, and these inhibitors have been used for cancer treatment[78] (Fig. 1).